A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT05948865 · RECRUITING
Trial details
- NCT number
- NCT05948865
- Sponsor
- Conjupro Biotherapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-06
- Primary completion
- 2027-05-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.